How much funding has AIRNA raised?

AIRNA has raised $245.0M in total funding, most recently a Series B round.

Who are AIRNA's investors?

AIRNA's investors include Forbion Capital Partners, Venrock, ARCH Venture Partners, RTW Investments, Nextech Invest, Ono Venture Investment.

Where is AIRNA headquartered?

AIRNA is headquartered in Cambridge, Massachusetts, United States.

What industry is AIRNA in?

AIRNA operates in Biotech, Healthcare.

AIRNA

A bold vision for genetic medicines

Cambridge, United States · Founded 2021 · $245.0M raised

Biotech

Healthcare

Headquarters: Cambridge, Massachusetts
Employees: 11–50
Founded: 2021
Business Model: B2B

Website: airna.com
Total Funding: $245.0M
Last Round: $155.0M Series BApr 2025
Rounds: 3

About

AIRNA is a clinical-stage biotechnology company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases. Founded in 2021 and headquartered in Cambridge, Massachusetts, with research operations in Tübingen, Germany, AIRNA harnesses the body's natural RNA-editing machinery to develop precision medicines. The company's lead program AIR-001 targets alpha-1 antitrypsin deficiency (AATD).

Summary

AIRNA is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $245.0M in total across 3 rounds, most recently a $155.0M Series B round in Apr 2025. Investors include Forbion Capital Partners, Venrock and ARCH Venture Partners.